Results 211 to 220 of about 64,470 (350)

Early Alzheimer's diagnosis: U.S. primary care physicians and use of blood biomarkers

open access: yesAlzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION We aimed to explore primary care physicians’ (PCP) attitudes, perceptions, and barriers toward Alzheimer's disease (AD) diagnosis and incorporating blood biomarker (BBM) tests into the diagnostic workflow. METHODS Remote 60‐min interviews with 20 PCPs were conducted (May 2023).
Jeffrey M. Burns   +6 more
wiley   +1 more source

Clinical, neuropsychological, and metabolic characteristics of transient epileptic amnesia syndrome

open access: yesEpilepsia, 2014
Amel Mosbah   +7 more
semanticscholar   +1 more source

The microbiota–gut–brain axis in mild cognitive impairment and Alzheimer's disease: a scoping review of human studies

open access: yesAlzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract Alzheimer's disease (AD) is projected to become the highest‐burden neurological disorder globally. Mounting evidence implicates the gut microbiome in AD pathogenesis. This scoping review of gut microbiomes in mild cognitive impairment (MCI) and AD included dietary and probiotic interventions.
Alison Warren   +10 more
wiley   +1 more source

Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers

open access: yesAlzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION “SuperAgers” are oldest‐old adults (ages 80+) whose memory performance more closely resembles middle‐aged adults. The present study examined apolipoprotein E (APOE) allele frequency in non‐Hispanic Black (NHB) and non‐Hispanic White (NHW) SuperAgers compared to controls and Alzheimer's disease dementia cases.
Alaina Durant   +38 more
wiley   +1 more source

Memory and amnesia. [PDF]

open access: green, 1990
AP Shimamura
openalex  

Home - About - Disclaimer - Privacy